Shares of Clorox Company (The) (NYSE:CLX) have been assigned an average rating of “Hold” from the fourteen analysts that are covering the company, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and three have given a buy recommendation to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $126.88.

Several brokerages have weighed in on CLX. Jefferies Group LLC reiterated a “hold” rating and issued a $137.00 target price (up from $136.00) on shares of Clorox Company (The) in a report on Wednesday, August 9th. Royal Bank Of Canada restated a “hold” rating and set a $115.00 price objective on shares of Clorox Company (The) in a research note on Wednesday, August 2nd. Zacks Investment Research upgraded Clorox Company (The) from a “sell” rating to a “hold” rating in a research note on Monday, November 6th. BMO Capital Markets set a $150.00 price objective on Clorox Company (The) and gave the stock a “buy” rating in a research note on Thursday, August 3rd. Finally, BidaskClub upgraded Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research note on Monday, July 31st.

In related news, EVP James E. Foster sold 9,861 shares of the company’s stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the transaction, the executive vice president now directly owns 22,069 shares of the company’s stock, valued at approximately $3,056,777.19. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Matthew T. Laszlo sold 20,051 shares of the company’s stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total value of $2,615,853.46. Following the transaction, the senior vice president now directly owns 10,896 shares in the company, valued at $1,421,492.16. The disclosure for this sale can be found here. Insiders have sold a total of 41,293 shares of company stock worth $5,560,303 over the last ninety days. 1.00% of the stock is currently owned by corporate insiders.

Several hedge funds have recently made changes to their positions in CLX. Janus Henderson Group PLC increased its holdings in shares of Clorox Company (The) by 8,008.5% in the second quarter. Janus Henderson Group PLC now owns 1,323,475 shares of the company’s stock valued at $176,340,000 after purchasing an additional 1,307,153 shares during the period. Vanguard Group Inc. increased its holdings in shares of Clorox Company (The) by 2.6% in the second quarter. Vanguard Group Inc. now owns 14,534,634 shares of the company’s stock valued at $1,936,595,000 after purchasing an additional 369,918 shares during the period. APG Asset Management N.V. increased its holdings in shares of Clorox Company (The) by 30.9% in the third quarter. APG Asset Management N.V. now owns 1,301,915 shares of the company’s stock valued at $171,736,000 after purchasing an additional 307,700 shares during the period. Ameriprise Financial Inc. increased its holdings in shares of Clorox Company (The) by 24.6% in the second quarter. Ameriprise Financial Inc. now owns 1,341,272 shares of the company’s stock valued at $178,433,000 after purchasing an additional 265,200 shares during the period. Finally, Renaissance Technologies LLC increased its holdings in shares of Clorox Company (The) by 24.5% in the second quarter. Renaissance Technologies LLC now owns 1,341,400 shares of the company’s stock valued at $178,728,000 after purchasing an additional 263,700 shares during the period. 72.74% of the stock is currently owned by institutional investors and hedge funds.

WARNING: This news story was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this news story on another publication, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this news story can be read at https://www.dailypolitical.com/2017/11/20/clorox-company-the-clx-given-consensus-recommendation-of-hold-by-brokerages.html.

Shares of Clorox Company (NYSE:CLX) traded down $1.03 during mid-day trading on Monday, hitting $133.51. The company’s stock had a trading volume of 633,100 shares, compared to its average volume of 815,117. Clorox Company has a twelve month low of $112.28 and a twelve month high of $141.76. The stock has a market cap of $17,380.00, a PE ratio of 24.06, a price-to-earnings-growth ratio of 3.64 and a beta of 0.39. The company has a quick ratio of 0.77, a current ratio of 1.10 and a debt-to-equity ratio of 3.02.

Clorox Company (The) (NYSE:CLX) last issued its earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.41 by $0.05. Clorox Company (The) had a return on equity of 161.59% and a net margin of 11.84%. The business had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same period in the prior year, the business earned $1.36 EPS. The business’s revenue for the quarter was up 4.0% compared to the same quarter last year. analysts forecast that Clorox Company will post 5.58 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be given a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a yield of 2.52%. The ex-dividend date of this dividend is Tuesday, January 23rd. Clorox Company (The)’s dividend payout ratio is currently 61.65%.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.